Press Releases
Quaker Chemical Corporation Announces First Quarter 2012 Results
First Quarter 2012 Summary
Net sales for the first quarter of 2012 were
Gross profit increased by approximately
Selling, general and administrative expenses ("SG&A") increased approximately
The Company's low first quarter of 2012 and first quarter of 2011 effective tax rates include the expiration of applicable statutes of limitations for uncertain tax positions of approximately
Equity in net income of associated companies decreased in the first quarter of 2012 as compared to the first quarter of 2011, primarily due to the Company's
Balance Sheet and Cash Flow Items
Net operating cash flow was
Forward-Looking Statements
This release contains forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from those projected in such statements. A major risk is that the Company's demand is largely derived from the demand for its customers' products, which subjects the Company to downturns in a customer's business and unanticipated customer production shutdowns. Other major risks and uncertainties include, but are not limited to, significant increases in raw material costs, customer financial stability, worldwide economic and political conditions, foreign currency fluctuations, and future terrorist attacks such as those that occurred on
Conference Call
As previously announced,
About Quaker
Quaker Chemical Corporation |
||||
Condensed Consolidated Statement of Income |
||||
(Dollars in thousands, except per share data and share amounts) |
||||
(Unaudited) |
||||
Three Months Ended March 31, |
||||
2012 |
2011 |
|||
Net sales |
$ 177,638 |
$ 159,865 |
||
Cost of goods sold |
117,843 |
107,131 |
||
Gross profit |
59,795 |
52,734 |
||
% |
33.7% |
33.0% |
||
Selling, general and administrative expenses |
43,093 |
38,634 |
||
Operating income |
16,702 |
14,100 |
||
% |
9.4% |
8.8% |
||
Other income, net |
341 |
539 |
||
Interest expense |
(1,174) |
(1,218) |
||
Interest income |
123 |
272 |
||
Income before taxes and equity in net income of associated companies |
15,992 |
13,693 |
||
Taxes on income before equity in net income of associated companies |
3,445 |
2,822 |
||
Income before equity in net income of associated companies |
12,547 |
10,871 |
||
Equity in net income of associated companies |
146 |
359 |
||
Net income |
12,693 |
11,230 |
||
Less: Net income attributable to noncontrolling interest |
747 |
630 |
||
Net income attributable to Quaker Chemical Corporation |
$ 11,946 |
$ 10,600 |
||
% |
6.7% |
6.6% |
||
Per share data: |
||||
Net income attributable to Quaker Chemical Corporation Common Shareholders - basic |
$ 0.92 |
$ 0.92 |
||
Net income attributable to Quaker Chemical Corporation Common Shareholders - diluted |
$ 0.91 |
$ 0.91 |
Quaker Chemical Corporation |
||||
Condensed Consolidated Balance Sheet |
||||
(Dollars in thousands, except par value and share amounts) |
||||
(Unaudited) |
||||
March 31, |
December 31, |
|||
2012 |
2011 |
|||
ASSETS |
||||
Current assets |
||||
Cash and cash equivalents |
$ 18,964 |
$ 16,909 |
||
Accounts receivable, net |
162,464 |
150,676 |
||
Inventories |
75,588 |
74,758 |
||
Prepaid expenses and other current assets |
17,024 |
17,206 |
||
Total current assets |
274,040 |
259,549 |
||
Property, plant and equipment, net |
83,991 |
82,916 |
||
Goodwill |
59,064 |
58,152 |
||
Other intangible assets, net |
31,303 |
31,783 |
||
Investments in associated companies |
7,458 |
7,942 |
||
Deferred income taxes |
29,368 |
29,823 |
||
Other assets |
37,181 |
35,356 |
||
Total assets |
$ 522,405 |
$ 505,521 |
||
LIABILITIES AND EQUITY |
||||
Current liabilities |
||||
Short-term borrowings and current portion of long-term debt |
$ 607 |
$ 636 |
||
Accounts and other payables |
76,257 |
68,125 |
||
Accrued compensation |
9,906 |
16,987 |
||
Other current liabilities |
22,889 |
20,901 |
||
Total current liabilities |
109,659 |
106,649 |
||
Long-term debt |
47,900 |
46,701 |
||
Deferred income taxes |
7,236 |
7,094 |
||
Other non-current liabilities |
86,946 |
89,351 |
||
Total liabilities |
251,741 |
249,795 |
||
Equity |
||||
Common stock, $1 par value; authorized 30,000,000 shares; issued 12,950,752 |
12,951 |
12,912 |
||
Capital in excess of par value |
90,836 |
89,725 |
||
Retained earnings |
184,764 |
175,932 |
||
Accumulated other comprehensive loss |
(25,902) |
(29,820) |
||
Total Quaker shareholders' equity |
262,649 |
248,749 |
||
Noncontrolling interest |
8,015 |
6,977 |
||
Total equity |
270,664 |
255,726 |
||
Total liabilities and equity |
$ 522,405 |
$ 505,521 |
||
Quaker Chemical Corporation |
||||
Condensed Consolidated Statement of Cash Flows |
||||
For the three months ended March 31, |
||||
(Dollars in thousands) |
||||
(Unaudited) |
||||
2012 |
2011 |
|||
Cash flows from operating activities |
||||
Net income |
$ 12,693 |
$ 11,230 |
||
Adjustments to reconcile net income to net cash provided by (used in) operating activities: |
||||
Depreciation |
3,057 |
2,656 |
||
Amortization |
746 |
486 |
||
Equity in undistributed earnings of associated companies, net of dividends |
38 |
(262) |
||
Deferred compensation and other, net |
(103) |
1,967 |
||
Stock-based compensation |
1,186 |
868 |
||
Gain on disposal of property, plant and equipment |
(14) |
(40) |
||
Insurance settlement realized |
(483) |
(365) |
||
Pension and other postretirement benefits |
(2,357) |
(4,910) |
||
Decrease in cash from changes in current assets and current liabilities, net of acquisitions: |
||||
Accounts receivable |
(9,764) |
(12,478) |
||
Inventories |
352 |
(8,309) |
||
Prepaid expenses and other current assets |
(557) |
(2,397) |
||
Accounts payable and accrued liabilities |
1,938 |
4,455 |
||
Net cash provided by (used in) operating activities |
6,732 |
(7,099) |
||
Cash flows from investing activities |
||||
Investments in property, plant and equipment |
(3,178) |
(3,475) |
||
Proceeds from disposition of assets |
64 |
170 |
||
Insurance settlement received and interest earned |
18 |
22 |
||
Change in restricted cash, net |
465 |
343 |
||
Net cash used in investing activities |
(2,631) |
(2,940) |
||
Cash flows from financing activities |
||||
Proceeds from long-term debt |
1,350 |
10,000 |
||
Repayments of long-term debt |
(189) |
(231) |
||
Dividends paid |
(3,105) |
(2,701) |
||
Stock options exercised, other |
(1,288) |
(50) |
||
Excess tax benefit related to stock option exercises |
546 |
78 |
||
Net cash (used in) provided by financing activities |
(2,686) |
7,096 |
||
Effect of exchange rate changes on cash |
640 |
741 |
||
Net increase (decrease) in cash and cash equivalents |
2,055 |
(2,202) |
||
Cash and cash equivalents at the beginning of the period |
16,909 |
25,766 |
||
Cash and cash equivalents at the end of the period |
$ 18,964 |
$ 23,564 |
||
SOURCE
Mark A. Featherstone, Vice President and Chief Financial Officer, +1-610-832-4160